SEC Tracker
Get the app

Lantheus Holdings LNTH

Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Lantheus Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.

  1. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  2. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  3. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
  4. Halozyme Therapeutics HALO public float $4.5B, Jun 30, 2025
  5. Alkermes ALKS public float $4.7B, Jun 30, 2025